Showing results (461-470 of 645) with videos related to

Sort By:
Pageof 65
Journal of Cancer Research and Clinical Oncology|May 31, 2007
Thy-1 as a potential novel diagnostic marker for gastrointestinal stromal tumorsDespoina Oikonomou, Kambiz Hassan, Jussuf T Kaifi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 13, 2020
Prognostic value of positive histological margins in patients with pancreatic head ductal adenocarcinoma and lymph node involvement: an international multicentric studyGaëtan-Romain Joliat, Pierre Allemann, Ismail Labgaa, et al.
Human Pathology|March 10, 2009
HER-2 amplification is highly homogenous in gastric cancerAndreas H Marx, Lars Tharun, Johanna Muth, et al.
Human Pathology|July 27, 2010
Heterogenous high-level HER-2 amplification in a small subset of colorectal cancersAndreas H Marx, Eike C Burandt, Matthias Choschzick, et al.
Annals of Surgery|August 2, 2007
Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resectionsEmre F Yekebas, Lars Wolfram, Guellue Cataldegirmen, et al.
International Journal of Cancer|October 23, 2009
Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse modelStephanie J Gros, Thorsten Dohrmann, Kersten Peldschus, et al.
Gut|April 12, 2012
Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- miceFlorian Gebauer, Daniel Wicklein, Katrin Stübke, et al.
Critical Care (London, England)|December 10, 2013
Effects of thoracic epidural anesthesia on survival and microcirculation in severe acute pancreatitis: a randomized experimental trialKai A Bachmann, Constantin J C Trepte, Lena Tomkötter, et al.
Biomarkers in Medicine|January 13, 2018
Syndecan-1 as a biomarker for sepsis survival after major abdominal surgeryMaximilian S Holzmann, Martin S Winkler, Mike S Strunden, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|February 25, 2003
[Prognostic relevance of biological and molecular markers in oncology. Criteria for planning and interpreting studies]E Bollschweiler, P M Schneider, S P Mönig, et al.
Pageof 65